Unaudited Condensed Consolidated Statements of Stockholders Investment - USD ($) $ in Thousands		3 Months Ended
		May 01, 2021	May 02, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		$ 391,036	$ 328,983
Net income (loss)		84,766	(15,287)
Issuance of shares through the Company's equity plans		1,770	166
Purchase of shares under the stock repurchase program		(37,314)	(9,748)
Settlement of net share equity awards		(2,846)	(424)
Stock-based compensation		2,053	1,217
Balance-end of period		$ 439,466	304,567
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	[1]		$ (340)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)		39,380,000	39,141,000
Balance-beginning of period		$ 394	$ 391
Issuance of shares through the Company's equity plans (in shares)		179,000	114,000
Issuance of shares through the Company's equity plans		$ 1	$ 2
Balance-end of period (in shares)		39,559,000	39,255,000
Balance-end of period		$ 395	$ 393
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		194,534	188,879
Issuance of shares through the Company's equity plans		1,769	164
Stock-based compensation		2,053	1,217
Balance-end of period		198,356	190,260
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		858,951	784,942
Net income (loss)		84,766	(15,287)
Balance-end of period		$ 943,718	769,315
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	[1]		$ (340)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)		22,901,000	22,280,000
Balance-beginning of period		$ (662,843)	$ (645,229)
Purchase of shares under the stock repurchase program (in shares)		541,000	428,000
Purchase of shares under the stock repurchase program		$ (37,314)	$ (9,748)
Settlement of net share equity awards (in shares)		41,000	31,000
Settlement of net share equity awards		$ (2,846)	$ (424)
Balance-end of period (in shares)		23,484,000	22,739,000
Balance-end of period		$ (703,003)	$ (655,401)

[1] Adoption of Accounting Standards Update ("ASU") No. 2016-13, Topic 326, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 7, 2021.